These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31302289)

  • 1. Multidrug transporters of Candida species in clinical azole resistance.
    Prasad R; Nair R; Banerjee A
    Fungal Genet Biol; 2019 Nov; 132():103252. PubMed ID: 31302289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candida Efflux ATPases and Antiporters in Clinical Drug Resistance.
    Prasad R; Rawal MK; Shah AH
    Adv Exp Med Biol; 2016; 892():351-376. PubMed ID: 26721282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenicity and drug resistance in Candida albicans and other yeast species. A review.
    Mishra NN; Prasad T; Sharma N; Payasi A; Prasad R; Gupta DK; Singh R
    Acta Microbiol Immunol Hung; 2007 Sep; 54(3):201-35. PubMed ID: 17896473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candida albicans Clinical Isolates from a Southwest Brazilian Tertiary Hospital Exhibit MFS-mediated Azole Resistance Profile.
    Pinto ACC; Rocha DAS; Moraes DC; Junqueira ML; Ferreira-Pereira A
    An Acad Bras Cienc; 2019 Jul; 91(3):e20180654. PubMed ID: 31365653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug resistance in yeast Candida.
    Prasad R; Kapoor K
    Int Rev Cytol; 2005; 242():215-48. PubMed ID: 15598470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Octyl gallate reduces ABC multidrug transporter CaCdr1p expression and leads to its mislocalisation in azole-resistant clinical isolates of Candida albicans.
    Singh S; Fatima Z; Hameed S
    J Glob Antimicrob Resist; 2020 Sep; 22():497-503. PubMed ID: 32344123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Analysis of
    Kim SH; Iyer KR; Pardeshi L; Muñoz JF; Robbins N; Cuomo CA; Wong KH; Cowen LE
    mBio; 2019 Jan; 10(1):. PubMed ID: 30696744
    [No Abstract]   [Full Text] [Related]  

  • 8. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Sanglard D; Coste AT
    Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efflux pump proteins in antifungal resistance.
    Prasad R; Rawal MK
    Front Pharmacol; 2014; 5():202. PubMed ID: 25221515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the CDR1 efflux pump in clinical Candida albicans isolates is controlled by a negative regulatory element.
    Gaur NA; Manoharlal R; Saini P; Prasad T; Mukhopadhyay G; Hoefer M; Morschhäuser J; Prasad R
    Biochem Biophys Res Commun; 2005 Jun; 332(1):206-14. PubMed ID: 15896319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Combination Fluorescence Assay Demonstrates Increased Efflux Pump Activity as a Resistance Mechanism in Azole-Resistant Vaginal Candida albicans Isolates.
    Bhattacharya S; Sobel JD; White TC
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5858-66. PubMed ID: 27431223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A State-of-the-art Review and Prospective Therapeutic Applications of Prenyl Flavonoids as Chemosensitizers against Antifungal Multidrug Resistance in Candida albicans.
    Santi MD; Ortega MG; Peralta MA
    Curr Med Chem; 2022; 29(24):4251-4281. PubMed ID: 35139777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India.
    Mane A; Vidhate P; Kusro C; Waman V; Saxena V; Kulkarni-Kale U; Risbud A
    Mycoses; 2016 Feb; 59(2):93-100. PubMed ID: 26648048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New evidence that Candida albicans possesses additional ATP-binding cassette MDR-like genes: implications for antifungal azole resistance.
    Walsh TJ; Kasai M; Francesconi A; Landsman D; Chanock SJ
    J Med Vet Mycol; 1997; 35(2):133-7. PubMed ID: 9147273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quinidine drug resistance transporter knockout Candida cells modulate glucose transporter expression and accumulate metabolites leading to enhanced azole drug resistance.
    Qadri H; Haseeb Shah A; Ahmad Mir M; Fazal Qureshi M; Prasad R
    Fungal Genet Biol; 2022 Jul; 161():103713. PubMed ID: 35671978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azole resistance in Candida albicans from animals: Highlights on efflux pump activity and gene overexpression.
    Rocha MFG; Bandeira SP; de Alencar LP; Melo LM; Sales JA; Paiva MAN; Teixeira CEC; Castelo-Branco DSCM; Pereira-Neto WA; Cordeiro RA; Sidrim JJC; Brilhante RSN
    Mycoses; 2017 Jul; 60(7):462-468. PubMed ID: 28295690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of antifungal resistance mediated by ABC efflux pumps from Candida albicans functionally expressed in yeast.
    Schuetzer-Muehlbauer M; Willinger B; Egner R; Ecker G; Kuchler K
    Int J Antimicrob Agents; 2003 Sep; 22(3):291-300. PubMed ID: 13678837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of human P-glycoprotein-like molecule in azole-resistant Candida albicans from HIV+ patients.
    Stringaro A; Molinari A; Calcabrini A; Arancia G; Ceddia PG; Cianfriglia M; Poloni F; Mondello F; Angiolella L; De Bernardis F; Cassone A
    Microb Drug Resist; 2002; 8(3):235-44. PubMed ID: 12363014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of C-5 Sterol Desaturase Activity in
    Luna-Tapia A; Butts A; Palmer GE
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30323044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of Upc2p-Inducible
    Luna-Tapia A; Willems HME; Parker JE; Tournu H; Barker KS; Nishimoto AT; Rogers PD; Kelly SL; Peters BM; Palmer GE
    mBio; 2018 May; 9(3):. PubMed ID: 29789366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.